Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy
Urotensin II (UII) is a potential mediator in the pathogenesis of cardiovascular disease, and inhibition of its actions at the urotensin receptor (UT) has been shown to improve cardiac function and structural changes of the myocardium in a model of myocardial infarction. In this study we utilized a...
Saved in:
Main Authors: | Andrew R. Kompa, Bing H. Wang, Arintaya Phrommintikul, Pei Y. Ho, Darren J. Kelly, David J. Behm, Stephen A. Douglas, Henry Krum |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78249263484&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/50625 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy
by: Kompa A.R., et al.
Published: (2014) -
Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction
by: Arintaya Phrommintikul, et al.
Published: (2018) -
Overview of microRNAs in cardiac hypertrophy, fibrosis, and apoptosis
by: Wang, J, et al.
Published: (2020) -
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
by: Lavinia Tran, et al.
Published: (2018) -
HETEROCHROMATIN REMODELLING IN CARDIAC HYPERTROPHY
by: DING NING
Published: (2020)